• After matching, a total of 1126 patients were included in the study, with 563 patients in each of the intervention and control groups. (Table 1 ).
Medication adherence
• For the intervention group members, the PDC for antihypertensives improved by 17.3% (33.6) (p<0.001), compared with an increase of 13.8% (32.3) (p<0.001) in the control group. The DID increase of 3.5% (36.3) in PDC in intervention group over control group was statistically significant (p=0.022) ( Table 2 ).
• The GEE results revealed that compared with their matched controls, the intervention group members had significantly improved medication adherence after controlling for covariates (p=0.021).
a P values compare changes between the 6-month pre-and post-intervention using paired t-test.
b P values compare the difference-in-differences [changes in intervention group -changes in matched control groups] using paired t-test. 
Impact of a Telephonic Outreach Program on Medication Adherence in Medicare Advantage Prescription Drug (MAPD) Plan Beneficiaries

MTM intervention
• AvMed Health Plans, a Florida based Health Plan, contracted with the UF MTM CCC to provide their MAPD health plan members with live interactive telephonic assessments.
• The phone call included a live interactive conversation with the patient to assess the use of their medication(s); to identify potential barriers to medication adherence; to provide possible recommendations including patient education, solutions for obtaining timely medication refills, and interventions related to side effect resolution and cost-related issues.
Study design and population
• A retrospective analysis using AvMed Health Plans (Jan 2013 -Dec 2014) was conducted for the MAPD plan beneficiaries (Fig1).
• Patients were included if they were (1) ≥18 years of age; (2) prescribed at least 2 prescription claims of antihypertensives; (3) continuously enrolled for 6 months prior to and 6 months following the index date (Jan -Jul 2014).
• A pre-post comparison study design with a matched control group (difference-indifferences analysis) was employed.
Data Analysis
• Medication adherence was defined by the Proportion of Days Covered (PDC), the number of days during the study period that the patient had medications on hand. 6 • A 1:1 propensity score matching technique was used to pair each patient in the intervention group with one individual from the control group.
• A Generalized Estimating Equation (GEE) model using the gamma family with a log link was used controlling for age, gender, county, pre-index PDC, therapy pattern, and index month.
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This study was funded by Florida Department of Health. • The impact of pharmacist-managed MTM programs has been positive, with several studies reporting improvements in clinical and economic outcomes. [1] [2] [3] [4] • However, most research on MTM programs has been conducted in the private insurance setting. Little is known about how the MTM programs affect medication adherence in elderly Medicare beneficiaries with chronic conditions.
• The University of Florida Medication Therapy Management Communication and Care Center (UF MTMCCC), established in 2010, educates fourth-year student pharmacists, provides experimental practice sites and facilitates the delivery of MTM and other patient care services by clinical pharmacists. 5 • To understand the effects of MTM program in elderly population, provided by the first student-staff MTM center, this study assessed the impact of MTM reminder call services on medication adherence among MAPD beneficiaries.
BACKGROUND & OBJECTIVE METHODS
• The findings of the present study suggest that the telephonic reminder calls delivered by campus-based MTM center was effective in improving adherence to antihypertensives among MAPD plan beneficiaries.
• The UF MTMCCC started providing the advanced adherence services in 2015 including all aspects of the basic reminder call services with the addition of incorporating a validated survey tool for assessing adherence barriers and offering various reminder tools targeted at patient-specific adherence barriers.
• Further research is needed to evaluate which type of service would be more effective in improving medication adherence.
Limitations
• As a general limitation with the use of claims databases, PDC was used as proxy measure of adherence. Thus, it cannot be ascertained whether patients actually used the medications as prescribed, but merely that they had their medications filled. 6 • The 6-month time period analyzed may not have been enough time to capture a significant impact of the adherence program, especially for those receiving a 90-day supply of medications. 
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